Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06125743 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

Name: Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial] — clinical trial record (NCT06125743)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot applicable

SponsorAbramson Cancer Center at Penn Medicine

Started2024-03-29

View on ClinicalTrials.gov ↗

The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.

Amendment history 2 changes detected by DataLookout

2026-09-05

Primary completion pushed: 2026-08-31 → 2027-08-31

2026-09-05

Completion pushed: 2026-08-31 → 2027-08-31

Trial Details

NCT Number	NCT06125743
Lead Sponsor	Abramson Cancer Center at Penn Medicine Collaborators: United States Department of Defense
Conditions	Lymphedema of the Head and Neck
Enrollment	204 participants
Start Date	2024-03-29
Primary Completion	2027-08-31 (estimated)
Study Completion	2027-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-04